Hanne Hella

751 total citations
18 papers, 554 citations indexed

About

Hanne Hella is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Hanne Hella has authored 18 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Hematology and 5 papers in Oncology. Recurrent topics in Hanne Hella's work include Multiple Myeloma Research and Treatments (9 papers), TGF-β signaling in diseases (8 papers) and Heterotopic Ossification and Related Conditions (3 papers). Hanne Hella is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), TGF-β signaling in diseases (8 papers) and Heterotopic Ossification and Related Conditions (3 papers). Hanne Hella collaborates with scholars based in Norway, Sweden and United Kingdom. Hanne Hella's co-authors include Toril Holien, Anders Sundan, Anders Waage, Thea Kristin Våtsveen, Oddrun Elise Olsen, Kristine Misund, Karin Fahl Wader, Ingerid Nesthus, Ingemar Turesson and Anne K. Mylin and has published in prestigious journals such as Blood, The Journal of Immunology and Scientific Reports.

In The Last Decade

Hanne Hella

18 papers receiving 550 citations

Peers

Hanne Hella

HEMAT

ONCOL

PRM

RHEUM

Tong Sun United States

Xiaokai Yan China

Julie Madden United Kingdom

Camelia Iancu‐Rubin United States

Sophie Derenne France

Anand Jillella United States

Takuma Ishizaki Japan

Uwe Jerke Germany

Raymond D. Pastore United States

Manuela Puopolo Italy

Tong Sun United States

Hanne Hella

367 ×1.0

195 ×1.2

HEMAT

109 ×0.9

ONCOL

53 ×0.6

PRM

70 ×0.9

RHEUM

Citations per year, relative to Hanne Hella Hanne Hella (= 1×) peers Tong Sun

Countries citing papers authored by Hanne Hella

Since Specialization

Citations

This map shows the geographic impact of Hanne Hella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanne Hella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanne Hella more than expected).

Fields of papers citing papers by Hanne Hella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanne Hella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanne Hella. The network helps show where Hanne Hella may publish in the future.

Co-authorship network of co-authors of Hanne Hella

This figure shows the co-authorship network connecting the top 25 collaborators of Hanne Hella. A scholar is included among the top collaborators of Hanne Hella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanne Hella. Hanne Hella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Mjelle, Robin, et al.. (2024). Toll-like receptor signaling in multiple myeloma cells promotes the expression of pro-survival genes B-cell lymphoma 2 and MYC and modulates the expression of B-cell maturation antigen. Frontiers in Immunology. 15. 1393906–1393906. 3 indexed citations

Moen, Siv Helen, et al.. (2024). Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma. Scientific Reports. 14(1). 3643–3643. 7 indexed citations

Liu, Bin, Paul D. Upton, Oddrun Elise Olsen, et al.. (2023). High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells. Scientific Reports. 13(1). 6639–6639. 2 indexed citations

Jatzlau, Jerome, Hanne Hella, Oddrun Elise Olsen, et al.. (2023). FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells. Cell Communication and Signaling. 21(1). 25–25. 4 indexed citations

Moen, Ingrid, et al.. (2021). TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan. Oncotarget. 12(21). 2158–2168. 7 indexed citations

Olsen, Oddrun Elise, et al.. (2020). Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors. Biomolecules. 10(4). 519–519. 38 indexed citations

Westhrin, Marita, Toril Holien, Muhammad Asif Zahoor, et al.. (2019). Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone. JBMR Plus. 4(1). e10247–e10247. 9 indexed citations

Olsen, Oddrun Elise, Hanne Hella, Glenn Buene, et al.. (2018). BMPR2 inhibits activin and BMP signaling via wild-type ALK2. Journal of Cell Science. 131(11). 42 indexed citations

Holien, Toril, Marita Westhrin, Siv Helen Moen, et al.. (2018). BMP4 Gene Therapy Inhibits Myeloma Tumor Growth, but Has a Negative Impact on Bone. Blood. 132(Supplement 1). 1928–1928. 1 indexed citations

10.

Starheim, Kristian K., Toril Holien, Kristine Misund, et al.. (2016). Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells. Blood Cancer Journal. 6(7). e446–e446. 48 indexed citations

11.

Moen, Siv Helen, Marita Westhrin, Muhammad Asif Zahoor, et al.. (2016). Caspase‐8 regulates the expression of pro‐ and anti‐inflammatory cytokines in human bone marrow‐derived mesenchymal stromal cells. Immunity Inflammation and Disease. 4(3). 327–337. 11 indexed citations

12.

Olsen, Oddrun Elise, Karin Fahl Wader, Hanne Hella, et al.. (2015). Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B. Cell Communication and Signaling. 13(1). 27–27. 124 indexed citations

13.

Holien, Toril, Oddrun Elise Olsen, Kristine Misund, et al.. (2013). Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate. European Journal Of Haematology. 91(4). 339–346. 35 indexed citations

14.

Holien, Toril, Thea Kristin Våtsveen, Hanne Hella, Anders Waage, & Anders Sundan. (2012). Addiction to c-MYC in multiple myeloma. Blood. 120(12). 2450–2453. 128 indexed citations

15.

Holien, Toril, Thea Kristin Våtsveen, Hanne Hella, et al.. (2011). Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC. Leukemia. 26(5). 1073–1080. 37 indexed citations

16.

Holien, Toril, Sofia Jönsson, Hanne Hella, et al.. (2010). CpG-Oligodeoxynucleotide Inhibits Smad-Dependent Bone Morphogenetic Protein Signaling: Effects on Myeloma Cell Apoptosis and In Vitro Osteoblastogenesis. The Journal of Immunology. 185(6). 3131–3139. 14 indexed citations

17.

Brenne, Anne‐Tove, Unn‐Merete Fagerli, John D. Shaughnessy, et al.. (2009). High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis. European Journal Of Haematology. 82(5). 354–363. 34 indexed citations

18.

Lamvik, Jon, et al.. (2001). Nonlabeled secondary antibodies augment/maintain the binding of primary, specific antibodies to cell membrane antigens. Cytometry. 45(3). 187–193. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact